Research

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

1 month ago   |   By Xconomy

Johnson & Johnson's global head of external innovation says there needs to be a shift in how healthcare research is funded to focus on early detection and curing rather than managing diseases. “When you look at the investment in research in the pharma industry, it's all designed to treat established diseases,” William Hait, global head of Johnson & Johnson External Innovation, told delegates at the BIO-Europe Spring event , held digitally last week due to the coronavirus crisis. While there have been notable exceptions-particularly in the cardiovascular diseases where Hait said it was...
Read more ...

 


Search by Tags

   Research      Pharma      Europe      Healthcare      Industrial      Europe top stories      National      National blog main      Apple      Auris Health      Big data      BIO Europe Spring      BIO-Europe      Biotech      Cancer      Cardio Vascular Disease      Clinical trials      Data      Deals      Drugs      Genomics      Healthtech      Innovation      J&J      Janssen      JLabs      Johnson & Johnson      Johnson & Johnson Development Corporation      Life Sciences      Robotics      Startups      Tech      Venture Capital      Wearables      William Hait      World Without Disease Accelerator  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

AbCellera Raises $105M to Advance Antibody Discovery Operations

AbCellera Raises $105M to Advance Antibody Discovery Operations

Most of the best-selling drugs worldwide today are antibodies, and in the three decades-plus since the first such drug was approved, makers of such treatments have begun... Read more ...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Xconomy Insight is excited to offer two special webinars to our community this June. Sponsored by Eurofins, registration is free to all. Screening Approaches for Reducing... Read more ...

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

With the year's biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the years to come. The drug... Read more ...

Unanswered Questions Drive Convalescent Plasma Research

Unanswered Questions Drive Convalescent Plasma Research

On Saturday, March 14, in southwest Wisconsin, a woman was working in her yard, raking and clearing the first spring weeds. She coughed a bit during the day, and felt some... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

Postdoctoral Associate - Sanford Burnham Prebys Medical Discovery Institute...

Provides independent experimental design and follow up planning, interpretation of results and evaluation of data. Professional proficiency in Microsoft Office.From Sanford... Read more ...